About: Incorporating Risk Stratification into the Practice of Pediatric Preventive Cardiology

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Incorporating Risk Stratification into the Practice of Pediatric Preventive Cardiology Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Incorporating Risk Stratification into the Practice of Pediatric Preventive Cardiology
Creator	Mccrindle, Brian Cardiology, Pediatric Kavey, Rae-Ellen Khoury, Michael Pierre, St, Julie
Source	Elsevier; Medline; PMC
abstract	Atherosclerosis in its earliest stages is associated with the same traditional cardiovascular disease (CVD) risk factors as are associated with manifest CVD events in adulthood. Clustering of risk factors is associated with exponential increases in atherosclerotic burden from a young age. Some medical conditions and risk behaviors occurring in children can either increase the likelihood of higher levels of risk factors (such as chronic kidney disease) or the presence of risk factor clustering (such as obesity and cardiometabolic syndrome), or are associated with acquired coronary artery pathology (such as Kawasaki disease). This creates a milieu for, or increases the impact of, accelerated atherosclerosis that in turn increases the likelihood of premature CVD. This review highlights the importance of considering the total risk factor and risk condition profile of pediatric patients. An algorithm is provided for stratifying patients into high, moderate and at risk categories, and practical examples are provided as to how the evaluation and management of one risk factor or risk condition might need to be intensified in the context of additional risk factors or risk conditions. For example, for treatment of an adolescent with familial hypercholesterolemia, the target low-density lipoprotein cholesterol level might be lowered by the concomitant presence of low high-density lipoprotein cholesterol or elevated lipoprotein(a) levels. As awareness of cardiovascular risk and atherosclerosis in pediatric patients increases, new at risk conditions that warrant consideration are emerging. The identification and management of high risk individuals is an important part of the overall practice of pediatric preventive cardiology.
has issue date	2020-07-14(xsd:dateTime)
bibo:doi	10.1016/j.cjca.2020.06.025
bibo:pmid	32679170
has license	no-cc
sha1sum (hex)	4e6e5b734e11a645a21dcad3703e58457c9e0237
schema:url	https://doi.org/10.1016/j.cjca.2020.06.025
resource representing a document's title	Incorporating Risk Stratification into the Practice of Pediatric Preventive Cardiology
has PubMed Central identifier	PMC7358764
has PubMed identifier	32679170
schema:publication	Can J Cardiol
resource representing a document's body	covid:4e6e5b734e11a645a21dcad3703e58457c9e0237#body_text
is schema:about of	named entity 'Cardiology' named entity 'Journal' named entity 'Cardiovascular' named entity 'Title' named entity 'primary prevention' named entity 'cardiovascular disease' named entity 'Risk Stratification' named entity 'Risk Stratification' named entity 'Short Title' named entity 'Pediatric' named entity 'medical diagnosis' named entity 'Nephropathy' named entity 'insulin' named entity 'sodium ions' named entity 'hypertriglyceridemia' named entity 'T2DM' named entity 'statin' named entity 'Subclinical' named entity 'aneurysms' named entity 'glycemic control' named entity 'health issues' named entity 'Autopsy studies' named entity 'risk behaviors' named entity 'genetic component' named entity 'pathophysiologic' named entity 'vascular assessment' named entity 'pediatric' named entity 'exercise bike' named entity 'mmol/L' named entity 'diabetes mellitus' named entity 'ventricular function' named entity 'Framingham Risk Score' named entity 'myofibroblastic' named entity 'percentile' named entity 'dyslipidemia' named entity 'T2DM' named entity 'aneurysms' named entity 'Pediatric patients' named entity 'atherosclerotic cardiovascular disease' named entity 'statin' named entity 'acute illness' named entity 'High-Risk' named entity 'diabetic nephropathy' named entity 'cardiovascular disease' named entity 'familial hypercholesterolemia' named entity 'visceral fat' named entity 'diastolic dysfunction' named entity 'hypertension' named entity 'pancreatitis' named entity 'blood pressure' named entity 'Kawasaki disease' named entity 'blood pressure' named entity 'United States' named entity 'statin' named entity 'autopsy' named entity 'longitudinal study' named entity 'HbA1c' named entity 'pancreatic β-cells' named entity 'general population' named entity 'fat' named entity 'insulin resistance' named entity 'Pediatric' named entity 'atherosclerosis' named entity 'atherosclerosis' named entity 'uremia' named entity 'inflammation' named entity 'cystic fibrosis' named entity 'coronary artery' named entity 'T2DM' named entity 'aneurysms' named entity 'cardiovascular disease' named entity 'simple carbohydrates' named entity 'exercise medicine' named entity 'medical conditions' named entity 'dyslipidemia' named entity 'statin'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software